Sanofi receives FDA complete response letter for MS drug tolebrutinib By Investing.com
SWI Editorial Staff2025-12-24T00:59:45-08:00Sanofi receives FDA complete response letter for MS drug tolebrutinib
Sanofi receives FDA complete response letter for MS drug tolebrutinib
Sanofi to acquire Dynavax for $2.2 billion in cash deal
Stonepeak to acquire majority stake in Castrol for $10.1 billion
Can Philips extend margin gains after FY25? Jefferies stays cautious
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: ...
Detailed price information for Meta Platforms Inc (META-Q) from The Globe and Mail including charting and trades.
MLex Summary: Meta Platforms risks distorting competition on the market for AI chatbots in Italy and has received an interim order to suspend a policy that would exclude rival services. ...
Ethereum price failed to continue higher above $3,000 and dipped. ETH is now showing bearish signs and might slide further below $2,880. Ethereum started a fresh decline below $3,000 and ...
Bitcoin (BTC), Ethereum (ETH) and Ripple (XRP) continue to trade in red on Wednesday as recent breakout attempts lose momentum near key resistance levels. BTC failed to reclaim the $90,000, ...
Price Analysis Dec 24, 2025 07:36 UTC Ethereum is trading in a derivatives-defined range, with options positioning reinforcing $3,000 as support and $3,200 as near-term resistance Without a surge in ...